ArticleClinics (Sao Paulo, Brazil)2026
A comparative benchmark of DeepSeek-R1 on the USMLE: surpassing human and AI performance averages.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe rapid advancement of Large Language Models (LLMs) has generated interest in their application to medical education, particularly for high-stakes assessments like the USMLE. This study aims to evaluate the performance of DeepSeek-R1, a state-of-the-art LLM developed in China, compared to OpenAI models, to assess its feasibility for medical education and assessment.
methodsThe authors evaluated the performance of five models, including DeepSeek-R1, DeepSeek-V3, and three OpenAI models (GPT-4 Omni, OpenAI o3-mini, OpenAI o1 pro), on 321 text-based USMLE-style questions. Accuracy rates were calculated, and statistical comparisons were performed using Chi-Square tests with Bonferroni correction.
resultsDeepSeek-R1 achieved the highest overall accuracy of 92.5% (95% CI 89.1%‒94.9%), significantly outperforming the OpenAI models (all 78.8%, p < 0.0001). DeepSeek-R1 also surpassed the reported average human examinee performance across all USMLE steps. The inter-model consensus between DeepSeek-R1 and OpenAI o1 pro yielded 94.9% accuracy, indicating high reliability for straightforward queries. Furthermore, in discordant cases, DeepSeek-R1 demonstrated superior capability with 82.8% accuracy compared to 14.1%‒28.1% for the OpenAI models (p < 0.0001).
conclusionDeepSeek-R1 emerges as a compelling candidate in the AI-driven healthcare landscape, demonstrating superior accuracy and reasoning capabilities. However, its current limitation in multimodal data processing underscores the need for further innovation. These findings provide valuable insights for educators and policymakers regarding the integration of non-Western LLMs into medical assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.